NCT06890208 (CLIMATE-III) is a clinical trial of No intervention in Coronary Disease, sponsored by Universitätsklinikum Hamburg-Eppendorf.

Who is sponsoring NCT06890208?

NCT06890208 is sponsored by Universitätsklinikum Hamburg-Eppendorf.

What drugs are being tested in NCT06890208?

Interventions in NCT06890208: No intervention.

What condition does NCT06890208 study?

NCT06890208 studies Coronary Disease, Myocardial Infarction, Heart Failure, Arrhythmias, Cardiac, Peripheral Artery Disease, Stroke, Ischemic Attack, Transient, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Pulmonary Disease, Chronic Obstructive, Asthma, Renal Insufficiency, Depressive Disorder, Anxiety Disorders, Schizophrenia, Peripheral Nervous System Diseases.

Is NCT06890208 still recruiting?

NCT06890208 is currently recruiting now. Last updated 29 June 2025.

Last reviewed 2025-06-29 · How we verify

NCT06890208: CLIMATE-III

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Chronical Illness-related Limitations of the Ability to Cope With Rising Temperatures, Third Wave

Recruiting now Last updated 29 June 2025

What this trial tests

trial testing No intervention in Coronary Disease in 240 participants. Currently enrolling.

Timeline

11 June 2025

Primary endpoint
15 September 2025

15 September 2025

Quick facts

Lead sponsor	Universitätsklinikum Hamburg-Eppendorf
Status	Recruiting now
Study type	OBSERVATIONAL
Enrollment	240
Start date	11 June 2025
Primary completion	15 September 2025
Estimated completion	15 September 2025
Sites	1 location across Germany

Drugs / interventions tested

No intervention

Conditions studied

Coronary Disease — all drugs for Coronary Disease →
Myocardial Infarction — all drugs for Myocardial Infarction →
Heart Failure — all drugs for Heart Failure →
Arrhythmias, Cardiac — all drugs for Arrhythmias, Cardiac →

Sponsor

Universitätsklinikum Hamburg-Eppendorf — full company profile →

Who can join

18 and older, any sex, with Coronary Disease or Myocardial Infarction. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The CLIMATE-III Observational Study examines to what extent chronically ill patients experience adverse health effects because of heat and whether the patients' specific health behavior, somatosensory amplification, risk and benefit perception, self-efficacy, health literacy, and the degree of urbanisation of the patients' administration district are associated with these effects. Study participants from Germany and Italy will be included in the sample.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other trials of No intervention

Trials testing the same drug.

NCT06643052 — Cahnge in Management of Suspected Early Onset Neonetal Sepsis After Assimilation of Early Onset Sepsis Calculator · not yet recruiting
NCT07540611 — Gonadotropin Therapy in Idiopathic Hypogonadal Non-Obstructive · NA · not yet recruiting
NCT07291778 — Doppler Evaluation for Congestive Acute Kidney Injury in Critical Illness · NA · not yet recruiting
NCT07490431 — An Observational Study to Learn More About How Elinzanetant is Used and How Well it Works for Women With Menopause Sympt · not yet recruiting
NCT07515365 — Colitis Patterns in Patients With Lower GI Symptoms · not yet recruiting

Other recruiting trials for Coronary Disease

Currently open trials in the same condition.

NCT06535568 — Single vs. Dual Antiplatelet Therapy in Elderly or HBR Patients Undergoing Percutaneous Intervention With DCB (PICCOLETO · NA · recruiting
NCT06736899 — Trial of Orbital Atherectomy Versus Standard Strategy in Calcified Bifurcation Lesions · NA · recruiting
NCT07094737 — The Italian Alliance for Cardiovascular Rehabilitation and Prevention (ITACARE-P) Registry: An Observational Study on Ca · recruiting
NCT06701968 — Effects of a Healthy Nordic Diet on Atherosclerosis in Patients with Coronary Heart Disease · NA · recruiting
NCT06831994 — Digital Implementation of the German S3 Clinical Practice Guideline for Multimorbidity · NA · recruiting

Other Universitätsklinikum Hamburg-Eppendorf trials

Trials by the same sponsor.

NCT07443384 — Complications Associated With Radiofrequency Microneedling in Dermatology: a Delphi Consensus · not yet recruiting
NCT07385092 — Continuous Vital Sign Monitoring Versus Routine Spot-checks in Patients After Non-cardiac Surgery · NA · recruiting
NCT07009522 — Hamburg Emotion Awareness and Regulation Group Training for Autistic Adolescents (HEART) · EARLY_PHASE1 · not yet recruiting
NCT07115394 — EEG Measurements to Capture DBS-induced Electric Potentials · recruiting
NCT06955884 — Patient Experience of Transoral Versus Transnasal Awake Tracheal Intubation · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT06890208 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Universitätsklinikum Hamburg-Eppendorf
Last refreshed: 29 June 2025

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06890208.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing